Basic Research Program through the National Research Foundation of Korea(NRF)funded by the Ministry of Science and ICT(No.NRF-2023R1A2C2005946).Korean NRF did not influence the drafting of the manuscript.
For intermediate-stage hepatocellular carcinoma(HCC)in the Barcelona Clinic Liver Cancer(BCLC),transarterial chemoembolization(TACE)is advised as the initial treatment.The term“BCLC intermediate-stage HCC”(BCLC stag...
While functioning as a boundary line,urban waterfront space has a unique charm created by the collision of two different geographical features.WATER has always played a vital role in the birth and progress of human ci...
While learning from others,China can contribute new technologies,work capacity,and industrial strength to restore harmony with nature.AS an architect and designer I have had the opportunity to combine my profession wi...
Hepatocellular carcinoma(HCC)is the most common primary liver malignancy and one of the most common causes of cancer-related death with the projection to increase during the next few decades(1).During the last 3 decad...
The study was approved by the Institutional Review Board of the Faculty of Medicine Vajira Hospital(No.COA 165/2564).
BACKGROUND The GALAD score has improved early hepatocellular carcinoma(HCC)detection rate.The role of the GALAD score in staging and predicting tumor characteristics or clinical outcome of HCC remains of particular in...
Hepatocellular carcinoma(HCC)remains the third most common cause of cancer-related deaths worldwide(1).Transarterial chemoembolization(TACE)has been established as a therapeutic option in those patients who are outsid...
This article presents the results of a study that evaluated VinclesBCN during COVID-19. This digital-based public social service aims to prevent loneliness and isolation in +65-year-old adults living in Barcelona. Thr...
The World WLAN Application Alliance(WAA),a non-profit independent organization,and Informa Tech held the roundtable meeting themed creating a secure and sustainable home Wi-Fi network on February 28 in Barcelona,Spain...
the Korea Health Technology R&D Project through the Korea Health Industry Development Institute,No.HR21C003000021.
BACKGROUND Patients with Barcelona clinic liver cancer(BCLC)stage B hepatocellular carcinoma(HCC)are considerably heterogeneous in terms of tumor burden,liver function,and performance status.To improve the poor surviv...